Yu Wang

Yu Wang

Auto-generated profile, based on publicly available information

Yu Wang

Sichuan University

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in World Neurosurgery
Verified
Journal Article
Closed access
YWYu Wang
Yu Wang
QDQingyu Dou
Qingyu Dou
JYJin Yang
Jin Yang
LZLifeng Zhang
Lifeng Zhang
YYYuqing Yan
Yuqing Yan
QKQingquan Kong
Qingquan Kong

1 July 2019 in World Neurosurgery
Verified
Journal Article
Closed access
JYJin Yang
Jin Yang
HWHao Wu
Hao Wu
QKQingquan Kong
Qingquan Kong
YWYu Wang
Yu Wang
ZPZhiyu Peng
Zhiyu Peng
DZDongfeng Zhang
Dongfeng Zhang

1 August 2019 in World Neurosurgery
Verified
Journal Article
Closed access
CGChuan Guo
Chuan Guo
DZDaiwen Zhu
Daiwen Zhu
QKQingquan Kong
Qingquan Kong
LZLifeng Zhang
Lifeng Zhang
YWYu Wang
Yu Wang
ZPZhiyu Peng
Zhiyu Peng

1 March 2020 in Annals of Palliative Medicine
Verified
Journal Article
Open access
PDF file
DHDong Huang
Dong Huang
YWYan Wang
Yan Wang
YWYu Wang
Yu Wang
ZLZong-An Liang
Zong-An Liang
Background: Tuberculosis and diabetes mellitus are both important global health problems now. Previous studies have drawn different conclusions about the impact of diabetes on drug resistance in patients with newly diagnosed tuberculosis. Methods: We conducted a systematic search in four databases: PubMed, EMBSE, Cochrane Library, and Web of Science. The relative risk (RR) was applied to assess the association of diabetes with drug resistance and the STATA version 12.0 was used for data synthesis. Results: A total of 13 studies involving 33,747 patients were included in our study. The pooled results revealed that presence of diabetes was significantly associated with isoniazid resistance (RR =1.22, 95% CI: 1.04–1.43) in patients with newly diagnosed tuberculosis. However, no significant impact of diabetes on rifampicin resistance (RR =0.67, 95% CI: 0.41–1.11) or multi-drug resistance (MDR) (RR =1.28, 95% CI: 0.93–1.75) was observed. The results of subgroup analysis were similar to the pooled results. No significant publication bias for the results of MDR was found. Conclusions: In patients with newly diagnosed tuberculosis, diabetes is associated with isoniazid resistance. However, there is no significant impact of diabetes on the rifampicin resistance or MDR. However, these findings still need to be verified in the future.

1 December 2018 in World Neurosurgery
Verified
Journal Article
Closed access
YYYuqing Yan
Yuqing Yan
YWYu Wang
Yu Wang
JYJin Yang
Jin Yang
HWHao Wu
Hao Wu
LZLifeng Zhang
Lifeng Zhang
QKQingquan Kong
Qingquan Kong

1 June 2019 in World Neurosurgery
Verified
Journal Article
Closed access
CGChuan Guo
Chuan Guo
LZLifeng Zhang
Lifeng Zhang
QKQingquan Kong
Qingquan Kong
YWYu Wang
Yu Wang
JYJin Yang
Jin Yang
ZPZhiyu Peng
Zhiyu Peng